Showing results (1-10 of 81) with videos related to
Sort By:
Pageof 9
Current Opinion in Gastroenterology|February 15, 2026
The alcohol-associated hepatitis treatment landscapeHanna Blaney, Amon AsgharpourMethods in Molecular Biology (Clifton, N.J.)|February 25, 2022
Generation of a Diet-Induced Mouse Model of Nonalcoholic Fatty Liver DiseaseAmon Asgharpour, Arun J SanyalGastroenterology & Hepatology|May 26, 2021
Smoking and Liver DiseaseStephanie M Rutledge, Amon AsgharpourHepatology International|August 31, 2015
Bile acids: emerging role in management of liver diseasesAmon Asgharpour, Divya Kumar, Arun SanyalGastroenterology Clinics of North America|February 9, 2020
Pharmacologic Treatment Strategies for Nonalcoholic SteatohepatitisJames Philip G Esteban, Amon AsgharpourACG Case Reports Journal|February 5, 2024
Spontaneous Hepatic Hemorrhage Causing Acute Liver Failure Requiring Liver TransplantKrunal Shukla, Rahul Chaudhari, Amon AsgharpourTranslational Gastroenterology and Hepatology|July 27, 2022
Evaluation of liver transplant candidates with non-alcoholic steatohepatitisJames Philip G Esteban, Amon AsgharpourClinical and Experimental Gastroenterology|September 17, 2013
Adalimumab treatment in Crohn's disease: an overview of long-term efficacy and safety in light of the EXTEND trialAmon Asgharpour, Jianfeng Cheng, Stephen J BickstonTranslational Gastroenterology and Hepatology|January 7, 2021
Basic science to clinical trials in non-alcoholic fatty liver disease and alcohol-related liver disease: collaboration with industryAmon Asgharpour, Amreen Dinani, Scott L FriedmanInfection and Immunity|July 26, 2005
Resistance to intestinal Entamoeba histolytica infection is conferred by innate immunity and Gr-1+ cellsAmon Asgharpour, Carol Gilchrist, Duza Baba, et al.Pageof 9